Asian Annals Click here to go to Medistim website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chandra, A.
Right arrow Articles by Naidu, M. S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chandra, A.
Right arrow Articles by Naidu, M. S.
Asian Cardiovasc Thorac Ann 1999;7:3-8
© 1999 Asia Publishing EXchange Pte Ltd


ORIGINAL CONTRIBUTION

Hyperbilirubinemia After Cardiopulmonary Bypass: A Prospective Study

Abha Chandra, MCh, Debasish Gupta, MD1,, K Sri Satya Saibaba, MD2,, Dronamraju Dilip, FRCS, Srinivas Kola, MS, Madhu Sudan Naidu, BSc, DPT

Department of Cardiovascular & Thoracic Surgery India
1 Department of Transfusion Medicine India
2 Department of Biochemistry Sri Venkateswara Institute of Medical Sciences Tirupati, Andhra Pradesh, India
For reprint information contact: Abha Chandra, MCh Tel: 91 8574 51222 Ext. 2378 Fax: 91 8574 28803 email: svims{at}ap.ap.nic.in Department of Cardiovascular & Thoracic Surgery, Sri Venkateswara Institute of Medical Sciences, Tirupati, AP 517507, India.
Postoperative hyperbilirubinemia is one of the complications of cardiopulmonary bypass. This prospective study was conducted on 77 patients who underwent open-heart surgery, to evaluate the incidence, risk factors, and prognostic significance of postoperative hyperbilirubinemia. Liver function tests were conducted preoperatively, immediately after surgery and on the 1st, 3rd, and 7th postoperative days. The overall incidence of postoperative hyperbilirubinemia was 26%. The incidence was significantly higher in patients who underwent prosthetic valve replacements (31%) than in those without prostheses (22%) and very high in patients undergoing double valve replacement (50%) compared to single valve replacement (27%). Most (90%) of the increase in serum bilirubin was due to a rise in unconjugated bilirubin on the 1st postoperative day. There was no mortality related to postoperative hyperbilirubinemia but it prolonged intensive care stay when it occurred early after surgery and prolonged hospital stay when it occurred later. Preoperative total bilirubin concentration, number of valves to be replaced, and preoperative high right atrial pressure were the factors associated with increased risk of postoperative hyperbilirubinemia by logistic regression analysis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1999 by the Asia Publishing EXchange Ltd.